| MATERIAL S AND ME THODS

| Participants
The retrospective observational study included 75 patients aged from 38 to 72 years, who paid for DFPP owing to hypertriglyceridemia (TG>2.26 mmol/L) in Taoyuan General Hospital from January of 2015 to March of 2018. Participants were followed up until June 30, 2018. We reviewed clinical characteristics and biochemical data 48 hours before apheresis and obtained blood samples after apheresis. All of them received single session of DFPP. Lipid-lowering agents were continued throughout treatment period. Thirteen subjects had history of acute pancreatitis owing to hypertriglyceridemia. None of them received interventions for coronary artery reperfusion. Nine participants without data on serum total protein were excluded. Finally, 66 participants were assessed and analyzed.
| Ethics
This study was conducted in accordance with the Declaration of Helsinki (2000) of the World Medical Association, and the protocol was approved by the institutional review board of Taoyuan General Hospital (TYGH107018). This study was investigated in a single center, and all patients in the study were directly diagnosed and followed up at Taoyuan General Hospital.
| Apheresis and Outcome ascertainment
Demographic data, clinical characteristics, and biochemical data were reviewed according to electronic medical records. Pretreatment blood samples were obtained in fasting status. DFPP was performed using the all-in-one blood purification device (HF440, Informed SA, Geneva, Switzerland). Plasma separators were used to separate plasma from blood with surface area 0.3 square meters (LF-030, Informed SA, Geneva, Switzerland), whereas the second hallow fibers were made of polyethersulfone with maximal pore size 30 nanometer (Medopen 30, INFOMED SA, Geneva, Switzerland). During apheresis, blood flow rate, plasma flow rate, TMP, arterial and venous pressures were monitored. Posttreatment blood samples were obtained at end of apheresis. One and a half estimated plasma volume was processed, which was estimated through the following equation: estimated plasma volume = (0.065 × wt(kg)]) × (1-Hct). 13 Normal saline 0.1 liters flushing in the circuit was launched automatically when TMP was higher than 150 mm Hg. Heparin was used as an anticoagulant. The plasma flow rate was 25% of blood flow rate. Since reducing effective apheresis duration could improve the clearance of TG and minimize the loss of albumin, we terminated apheresis when estimated plasma volume was fully processed or just after second normal saline flushing. 10 We used 18-gauge needles as vascular access in both antecubital veins.
| Laboratory test
Serum cholesterol, triglyceride, creatinine, LDL, albumin as well as total protein (reference range (60-83 g/L) and hematocrit (reference range: 39%-53% for men and 33%-47% for women) were measured before commencing apheresis (ADVIA 1800, Siemens, Germany and XN9000, Sysmex, Japan). The inter-assay coefficients of variance (CV%) for hematocrit and total protein were <2% and 1.4%, respectively; whereas intra-individual CV% for total protein and triglyceride were 2.8% and <10%. The triglyceride measurement was based on the enzymatic determination of glycerol using the enzyme glycerol phosphate oxidase (GPO) after hydrolysis by lipoprotein lipase, whereas hematocrit was measured by direct current detection method on microscopy. Total protein was measured by biuret reference method. WBV was estimated in centipoises (cP) at high shear rate (208 s −1 ) according to following equation as previous study 14 :
WBV = 0.12 × Hct + 0.17 × (total protein −2.07). The removal rate of triglyceride was calculated using the following formula: (pre-apheresis TG -post-apheresis TG)/pre-apheresis TG. Besides, the removal rate of cholesterol and LDL were also calculated as previous equation. Since the TG clearance rate in single session of lipid filtration was 50% on average, we defined those with a removal rate of TG less than 50% as inefficient TG removal in the modality. Technical parameters, such as total heparin dose, duration of apheresis, filtrated plasma volume, maximal transmembrane pressure, blood flow rate, plasma flow rate and volume of plasma processed, reflected by filtrated-to-estimated plasma volume ratio, were also recorded.
| Statistical analysis
Participants were divided into two groups, efficient TG removal A two-tailed p value of less than 0.05 was considered statistically significant.
Parameters at apheresis
TG removal <50% TG removal ≥50% 
| D ISCUSS I ON
This cross-sectional observational study demonstrated not only preapheresis triglyceride but also whole blood viscosity, estimated by hematocrit and total protein, was associated with the efficiency of lipid apheresis after multivariable logistic regression analysis. The TG removal rates between high WBV(>5.83cP) vs low WBC(<5.83cP)
were 56.8% vs 46%.
Several studies had demonstrated the associations between efficiency of lipid apheresis and blood flow rate, plasma flow rate, TMP as well as filtrated plasma volume. 10, 15 However, the association between pre-apheresis whole blood viscosity and efficiency of lipid apheresis has not been well investigated. Blood viscosity, reflected by hematocrit and total protein, might be associated with elevated TMP during apheresis. 12 Conceptually, TMP was different from viscosity. TMP was an indicator monitored during apheresis for patency of circuit and was influenced by length of circuit, blood viscosity, pore size of plasma separator or fractionator, arterial and venous pressures, 12 whereas blood viscosity could be estimated by hematocrit, total protein, lipid, temperature, and shear rate of blood vessel. [16] [17] [18] Moreover, blood viscosity was associated with gender, obesity, sodium intake, age, race, plasma renin activity, mean blood pressure, RBC aggregation, platelet activation and microcirculation status. [17] [18] [19] It was difficult to separate plasma from whole blood under hyperviscosity status, since blood viscosity was representative not only for high red blood cell mass but also hydrodynamics and macromolecule induced red blood cell aggregation. [19] [20] [21] On the other hand, the plasma from subjects with blood hyperviscosity but normal hematocrit was easily separated from blood cell via primary separator. However, the hyperviscosity was attributed not only to high hematocrit but also to high total protein. The protein-rich plasma would make second hallow fiber early saturated and reduced the efficiency of target molecule removal. Not surprisingly, high TG value was associated with high TMP during apheresis because of high blood viscosity with early saturation of plasma separator. 22 Nonetheless, the amplitude of rebound of TG was higher in those with higher TG removal rate than that of those with lower TG removal rate. 23, 24 Median recovery half times for lipid and lipoprotein range from 2.3 to 4 days. 23 Inefficient TG removal was not uncommon for those with low baseline TG values. Thus, whether higher triglyceride was associated, better extraction of TG remained controversy since hypertriglyceridemia was associated with high TMP and hyperviscosity but lower lipid was associated with higher amplitude of lipid rebound. Sigmoidal shape between serum triglyceride and TG removal rate might be reasonable. In the study, we demonstrated high pre-apheresis whole blood viscosity was a significant predictor for inefficient apheresis. Since we could adjust the ratio of plasma-to-blood flow rate during apheresis, lower ratio of plasmato-blood flow rate with lower blood viscosity might be necessary in those with higher pre-apheresis blood component, such as lipid, protein, and immunoglobulin.
The reported TG removal rate ranged from 38% to 58% in double filtration variant, whereas it was only 52% in our study. 10, 11 There were several reasons why the TG removal rate was lower and varied widely (8.9% ~ 91.3%) in our study. First, the estimated plasma volume was not totally processed. Some treatments were early protein-based blood viscosity formulae had be validated and hematocrit was the key factor, the influence of erythrocyte aggregation and deformity might be underestimated. 14, 17, 29 Although HDL, fibrinogen, TG may contribute to blood viscosity, their contribution and correlation to blood viscosity were minimal (Pearson's correlation coefficients <0.1). On the other hand, the correlation between hematocrit and viscosity as well as total protein was high (Pearson's correlation coefficients were 0.75 and 0.39). Total protein plus hematocrit could be a good surrogate for blood viscosity. Actually, real whole blood viscosity might had more impact on TG clearance since WBV was underestimated. 29, 30 The association between estimated WBV and TG clearance rate remained conclusive.
To sum up, hematocrit, WBV, estimated according to hematocrit and total protein, was associated with the efficiency of lipid apheresis. The impact of hyperviscosity on TG clearance rate was mainly attributed to hematocrit and total protein. Adjustment of ratio of plasma-to-blood flow rate during apheresis might increase clearance of triglyceride. Applications of apheresis were not only for hyperlipidemia, but also for hypercholesterolemia, sudden onset hearing loss, acute inflammatory demyelinating polyneuropathy, acute fatty liver, rapid progressive glomerulonephritis, and hyperviscosity syndrome. Optimal ratios of plasma-to-blood flow rate in different diseases and viscosity have not be established. This study was limited by the crosssectional and observational nature and sample size. A multicenter observational study is warranted to confirm the relationship between pre-apheresis blood viscosity and clearance of different molecule.
Optimal ratios of plasma-to-blood flow rate during apheresis will also need further investigation in different setting of diseases.
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